ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

WOK vs SNOA // DIVIDEND YIELD & FCF PAYOUT SAFETY

WORK Medical Technology Group LTD (Class A) (NASDAQ) VS. Sonoma Pharmaceuticals Inc. (NASDAQ) • 15-METRIC TALLY: WOK 0 — SNOA 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (WOK VS. SNOA) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC WOK SNOA SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 38.00% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) — -35.00% — TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin — -12.60% — TIE /operating-margins <GO>
Net Profit Margin — 0.00% — TIE /net-margins <GO>
Revenue Growth (YoY) — 36.70% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety ACTIVE 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 4/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 27.8 39.8 -11.97 SNOA /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $4.9M $5.7M -$831.8K SNOA /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR WOK REV SNOA REV WOK GROSS % SNOA GROSS % WOK FCF SNOA FCF
FY 2025 $0 $19.5M — 38.0% $4.9M -$4.1M
FY 2024 $0 $14.3M — 38.2% -$11.5M -$168.0K
FY 2023 $0 $12.7M — — $2.2M -$2.4M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
WOK // BETA —
SNOA // BETA —